key: cord-1016315-aplq7d4q
authors: de Beurs, Edwin; Blankers, Matthijs; Peen, Jaap; Rademacher, Clara; Podgorski, Alicja; Dekker, Jack
title: Impact of COVID‐19 social distancing measures on routine mental health care provision and treatment outcome for common mental disorders in the Netherlands
date: 2022-02-02
journal: Clin Psychol Psychother
DOI: 10.1002/cpp.2713
sha: c03c1fadb773c46621c5978da4f51c9d9e54ea2d
doc_id: 1016315
cord_uid: aplq7d4q

OBJECTIVE: The uptake of digital interventions in mental health care (MHC) has been slow, as many therapists and patients believe that in‐person contact is essential for establishing a good working relationship and good outcomes in treatment. The public health policies regarding social distancing during the coronavirus disease‐2019 (COVID‐19) pandemic forced an abrupt transformation of MHC provisions for outpatients: Since mid‐March 2020, nearly all in‐person contact was replaced with videoconferencing. The COVID‐19 crisis offered a unique opportunity to investigate whether MHC with videoconferencing yields inferior results as compared to in‐person interventions. METHOD: In a large urban MHC facility in the Netherlands, measurement‐based care is routine practice. Outcome data are regularly collected to support shared decision making and monitor patient progress. For this study, pretest and post‐test data were used to compare outcomes for three cohorts: treatments performed prior to, partially during and entirely during the COVID‐19 lockdown. Outcomes were compared in two large data sets: Basic MHC (N = 1392) and Specialized MHC (N = 1040). RESULTS: Therapeutic outcomes appeared robust for COVID‐19 conditions across the three cohorts: No differences in outcomes were found between treatments that were conducted during lockdown compared to in‐person treatments prior to COVID‐19, or treatments which started in‐person, but needed to be continued by means of videoconferencing. DISCUSSION: Videoconferencing care during the COVID‐19 pandemic had similar outcomes compared to traditional in‐person care. These real‐world results corroborate findings of previous randomized controlled studies and meta‐analyses in which videoconferencing and in‐person care has been directly compared in terms of clinical effectiveness.

The digitalization of health care is rapidly progressing (Fairburn & Patel, 2017) , a process amplified by the recent coronavirus disease-2019 (COVID-19) epidemic (Pierce et al., 2021; Probst et al., 2020; Wind et al., 2020; Wosik et al., 2020) . The widespread use of internet, computers and smartphones has facilitated remote contact between individuals (Goodman-Deane et al., 2016) , and digital tools such as videoconferencing closely mimic in-person communication (Krouwel et al., 2019) . The implications for the delivery of health care are substantial: Treatment providers use patient portals to facilitate the transfer of information to and from patients, easily accessible (medical) information abounds, and many applications dedicated to health education and management have become available. These new tools are particularly interesting as they bring about new options for delivery of psychological treatment. Clients can now be treated remotely through the use of these digital tools. For instance, delivery of treatment through videoconferencing has been applied to various formats and types of psychotherapy (Backhaus et al., 2012) .

There is a long-standing tradition with internet-based mental health care (MHC) in the Netherlands, starting in 1996 with Interapy, an asynchronous email-based approach with writing assignments for PTSD patients (Lange et al., 2001) . Videoconferencing treatment has also been around for quite some time in MHC (Richardson et al., 2009) , but its uptake is slower in MHC as compared to other fields of health care, and widespread implementation in routine psychotherapeutic care is still lacking (Vis et al., 2018) . A potential barrier for the implementation of treatment via videoconferencing may be the perspective that in-person communication is a requisite for therapeutic change in psychotherapy, which deems in-person contact crucial to the establishment of a good therapeutic working relation (Connolly et al., 2020) . Many practitioners in MHC feel that treatment delivery in a videoconferencing format is ultimately inferior to inperson therapy (Humer et al., 2020) . Practitioners also state that they feel less confident when delivering therapy in this form (Aafjes-van Doorn et al., 2020; Békés et al., 2021) . The latter authors mention a decrease in confidence among therapists because they are afraid of not being fully attentive themselves or that their clients are easily distracted. Furthermore, this lack of confidence also results from the fear of encountering technical difficulties, which used to accompany treatment via videoconferencing (Fletcher-Tomenius & Vossler, 2009 ). The limitations of videoconferencing, as perceived by therapists, are also related to the absence of non-verbal cues, the possibility of missing out on important information and the difficulty in dealing with possible crisis situations through a digital medium (de Beurs et al., 2021b) .

Finally, compared to blended digital treatments (a mix of in-person and videoconferencing or other forms of digital care), treatments without any in-person contact are perceived as less advantageous and risky (Schuster et al., 2018) . This concern is substantiated with research on patients' adherence to digital MHC, which has found that adherence can be poor, especially to free-to-access programs (Christensen et al., 2009) . However, adherence to treatment is substantially higher when digital MHC is provided in the context of a randomized controlled trial (RCT) (Cuijpers et al., 2016) , and adjunctive measures, such as weekly phone calls, appear to further improve adherence (Mohr et al., 2010) .

To a large extent, patients mirror the concerns of their therapists.

Two reviews of research into client preferences show that the vast majority of patients prefer in-person contact over treatment delivered via videoconferencing (March et al., 2018; Meurk et al., 2016) , mainly because they expect more benefits from in-person treatment. However, when asked if they would like to give it a try, many clients are open to treatment via videoconferencing, and those who have already gained experience with this form of treatment are indeed more likely to opt for it again (March et al., 2018) . Recently, we conducted a survey among patients of our institution (Arkin, the largest MHC provider of Amsterdam, the Netherlands) on how they experienced videoconferencing treatment under COVID-19 social distancing measures and found that patients reported benefits from the treatment. Still, most patients preferred a return to in-person treatment or opted for blended in-person and videoconferencing when social distancing was no longer required (de Beurs et al., 2021a) . In sum, it seems that progress with the implementation of remote care has been hampered mainly by negative perceptions, both among professionals and clients.

Negative perceptions of therapists and clients towards treatment through videoconferencing are partly due to negative expectancies of its benefits. Research, investigating the effectiveness of digital treatments, does not support the negative attitude towards videoconferencing treatment. Results of several RCTs suggest that guided internet-based interventions are equally effective as in-person treatment of common mental disorders (Andrews et al., 2010; Cuijpers et al., 2017; Karyotaki et al., 2018) . Based on this research, treatment via videoconferencing seems to be a good alternative to the conventional in-person approach to therapy. But professionals and clients are not convinced. They note that these findings are predominantly based on RCT studies (e.g., Andrews et al., 2010; Cuijpers et al., 2017) . RCTs are the gold standard for evaluating new treatments or modes of treatment delivery, as randomization can effectively counter biasing effects of confounders, thus optimizing internal validity of a study comparing modes of treatment delivery. However, optimizing internal validity can be at the expense of external validity. When the effectiveness of videoconferencing treatment is evaluated under controlled conditions, participants of the study are randomly assigned to either in-person or videoconferencing treatment conditions. In order to be randomized, both client and therapist must be open to both forms of

• Under COVID-19 circumstances, treatments were almost exclusively provided through videoconferencing.

• Videoconferencing treatment was not less effective than in-person treatment.

• Treatment outcome for common mental disorders appears robust for the impact of COVID-19. treatment, which might cause a selective inclusion of study subjects where only therapists and clients partake with a favourable view on videoconferencing treatment. Consequently, it is unclear whether the similar outcomes for videoconferencing and face-to face treatment can be generalized to everyday clinical practice. It is important to investigate how conventional in-person treatment and delivery via videoconferencing compare in everyday clinical practice. The recent COVID-19 has offered a prime opportunity to do so. Wind et al. (2020) describe the recent outbreak of COVID-19 as the 'black swan virus' for e-mental health care. A 'black swan' is an unforeseen event that changes everything (Blumenstyk, 2020) . Wind et al. (2020) imply that the viral outbreak resembles such an event and speculate that it introduced a shift from conventional in-person therapy to the use of videoconferencing, which will, at least partly, persist in the future. This shift is likely to benefit MHC, as the use of videoconferencing has the prospect of providing treatment more efficiently and will facilitate accessibility of treatment. Videoconferencing facilitates delivery of treatment to clients who live in rural areas and thus have difficulty attending in-person therapy (Schopp et al., 2006) .

For clients, the advantages of videoconferencing are as follows: no need to travel or in case of blended care, less often; and homework assignments can be executed more interactively as they can receive direct feedback from their therapist, and thus integrate therapy more easily in their everyday live. In addition, some clients may find it easier to disclose sensitive information online instead of in the therapists' room (Gega et al., 2004 )-lack of self-disclosure is a common issue in psychotherapy (Knox & Hill, 2016 )-while others find it harder to establish sufficient trust online (Cataldo et al., 2021) .

In any case, the outbreak of COVID-19 has offered a unique opportunity to investigate the effectiveness of treatment via videoconferencing under the natural conditions of everyday practice. The virus originated in China and within the course of only a few months led to the development of a global pandemic. As COVID-19 is highly communicable, drastic measures were taken to reduce human contact (Wu et al., 2020) . For the delivery of psychotherapy, in-person therapy was replaced by videoconferencing in the Netherlands after the COVID-19 measures came into effect at mid-March 2020. The measures sharply restricted person to person contact. Therefore, in the period from 2019 to 2021, some clients received their entire treatment in-person, some were treated initially in-person therapy but switched to delivery via videoconferencing, whereas others were treated entirely through videoconferencing. This study aims to compare the process of treatment and treatment outcome of patients who received treatment provided online in a synchronous manner via videoconferencing to patients who received in-person treatment prior to the corona crisis, and to patients who received a mix of videoconferencing and in-person treatment.

In sum, the current study aims to investigate the effectiveness of treatment via videoconferencing in everyday practice, using as a natural experiment the opportunity offered by the recent COVID-19 measures limiting in-person contact in the psychotherapeutic context. Based on therapists' and clients' expectancies, we hypothesized the following effect of the treatment delivery mode: a diminished outcome for treatments that were conducted via videoconferencing, as compared to in-person treatments or treatments that started as in-person but continued via videoconferencing on 16 March 2020. 2 | METHOD

This study took place at two ambulatory clinics of Arkin, the major MHC provider in Amsterdam. One is called Basis GGZ and provides 

This study made use of a two convenience samples of patients with common mental disorders: One sample was comprised of patients were included. According to Dutch law, use of anonymized data, which is routinely collected as part of everyday treatment and intended to support shared decision making, quality control and research, is exempt from an informed consent procedure.

In the B-MHC sample, 66.7% of the participants identified themselves as female and were between 18 and 83 years of age (M = 36.9, SD = 13.4); 37.5% of the clients had a diagnosis of mood disorder, and 20.8% were diagnosed with an anxiety disorder. The remaining 41.7% of clients were diagnosed with other disorders, such as PTSD and adjustment disorder, or did not meet criteria for a DSM-5 disorder.

In the S-MHC sample, 64.5% of the participants identified themselves as female and were between 18 and 72 years of age (M = 36.4, SD = 12.5); 54.5% had a mood disorder, and 26.1% were diagnosed with an anxiety disorder. The remaining 19.4% of clients were de BEURS ET AL. diagnosed with other mental disorders, such as a psychotic disorder or no disorder. Table 1 provides an overview of the characteristics of the two study samples.

Regarding demographics, both samples were similar; regarding severity and diagnoses, S-MHC sees more severe and complex cases with more comorbidity. There were more adjustment disorders and (mild) PTSD in B-MHC as compared to S-MHC. The low number of primary PTSD diagnoses in S-MHC is due to the fact that Arkin has a specific clinic specialized in the treatment of PTSD. Mean treatment duration in S-MHC was almost twice as long with three to four times more sessions.

The current study was a longitudinal observational study. All participants were assessed repeatedly with self-report questionnaires through Routine Outcome Monitoring (ROM; Carlier et al., 2012; de Beurs et al., 2011) . ROM is a method to monitor treatment progress by continuously or periodically measuring the nature and severity of the client's problems. The frequency of ROM assessments varies from a high-frequency, session-by-session approach to low frequency (e.g., every 6 weeks or 3 months). Low-frequency ROM is routine practice in the clinics of Arkin. According to the ROM approach implemented in B-MHC and S-MHC, the severity of symptoms and level of functioning were assessed at the beginning of treatment, and assessments were repeated approximately every 3 to 4 months during treatment to monitor symptom change and functioning.

In the S-MHC sample, we used the ROM assessments that were closest to the date of the first and the last treatment session to evaluate outcome. In order to homogenize the cohorts regarding their treatment duration, we limited our analysis in S-MHC to the first year of treatment; later ROM assessments were excluded. We analysed only data from the first year in order to evaluate treatment (sections) of similar duration. By May 2021, treatments provided under COVID-19 conditions had a maximum duration of 14 months. Otherwise, due to lengthy treatments, the three cohorts may diverge in average treatment length, which would provide an alternative explanation for differences in outcome among the cohorts. This was only relevant for S-MHC where one third of the treatments continue for longer than 1 year. In B-MHC, lengthy treatments (>1 year) were not present, and here, the first and the last ROM assessments were also used for pretest and post-test data.

Although ROM is routine practice in the Arkin clinics, not all patients completed all the assessments. Only treatments with complete pretest and post-test data for the first year were included, about 55% of all treatments that had been started, 43.8% of the S-MHC and 70.3% of the B-MHC treatments. We compared fully assessed treatments to treatments with incomplete data on pretest patient characteristics to check for selective ROM non-response (de Beurs, Warmerdam, & Twisk, 2019). Tables 2 and 3, respectively. (Jacobson & Truax, 1991) . We converted scores to T scores and used a cut-off of 5 T-score points as proposed by de Beurs, Carlier, and van Hemert (2019 providing an opportunity for the therapist and the client to become acquainted in. In case of significant pretest differences among the cohorts, demographics, diagnoses, functioning and treatment length could be included as covariates into the main analysis, as pretest differences may confound the results. In addition, treatment outcome categories (recovery, improvement, etc.) were compared between the three cohorts with a χ 2 test.

We used administrative data regarding the treatment delivery mode to assess videoconferencing use in the three treatment cohorts.

As an additional inspection of how videoconferencing may influence treatment outcome, the association between the percentage of videoconferencing and the pretest-to-post-test difference was calculated in the B-MHC sample and in the S-MHC sample and, within each sample, for the three cohorts. A significant association between the proportion of in-person contact and outcome, especially expected for the overall samples and for Cohort 2, would support our hypothesis of a diminished treatment outcome for videoconferencing treatment. Regarding demographic and clinical characteristics, the included patients were similar to those without sufficient ROM assessments.

At pretest, cohorts were similar in age and pretest severity of symptomatic distress but differed in functioning with the cohort treated prior to COVID-19 functioning better (F(2) = 6.51; p = .002). Women were overrepresented in the COVID-19 cohort in both settings.

Regarding the primary diagnosis, depression was somewhat lower, and anxiety and PTSD were somewhat higher in the COVID-19 cohort. Regarding comorbidity, cohorts were again similar. Treatments comprised of more sessions and were longer in duration in the second cohort, to aid with the transition from in-person to videoconferencing treatment. there were also no significant differences found.

The finding of noninferior outcomes for videoconferencing therapy was unexpected and striking, especially because conditions for its implementation were far from ideal: The transition was unplanned and sudden, and therapists were not trained in this delivery mode and had no experience with the software that was used; the latter also applied to the clients. Our surveys among professionals (de Beurs et al., 2021b) and clients (de Beurs et al., 2021a) revealed that there were initially problems with the use of software. Furthermore, the COVID-19 pandemic has consequences, beyond its implication for treatment delivery, such as a negative impact on mental health and well-being (Brooks et al., 2020; Fiorillo & Gorwood, 2020) . However, this also does not appear to lead to worse outcomes for MHC treatment for common mental disorders, as outcomes in this observational study remained the same in the three cohorts for both B-MHC and S-MHC. Importantly, patients treated predominantly through Videoconferencing treatment is still viewed as an inferior treatment option to in-person by many professionals and patients (Békés et al., 2021) . In our own surveys, among both groups, a majority indicated a preference for a return to in-person treatment or in-person blended with videoconferencing when COVID-19 lockdown restrictions are lifted (de Beurs et al., 2021a Beurs et al., , 2021b , stating that interpersonal contact and information transfer is leaner as non-verbal and implicit communication is lacking. However, a recent literature review (Cataldo et al., 2021) 

In B-MHC, we found a significant difference between the cohorts in premature terminations of treatment: A higher dropout rate occurred among treatments conducted (partially) during COVID-19 compared to treatments prior to COVID-19 (1.5 more dropouts). Furthermore, in B-MHC, the higher dropout rates during COVID-19 suggest that treatment via videoconferencing may be less acceptable for certain patients or their engagement or involvement may be diminished compared to in-person treatment. Similar findings have been reported for patient with PTSD (Valentine et al., 2020) .

In the S-MHC sample, where dropout was generally lower, we also found a difference in dropout rate between cohorts, but here, be generalized to patients who remain in treatment (Tierney & Stewart, 2005) .

Did a substantial group of patients discontinue treatment on 16 March 2020? If so, this could suggest a rival explanation for the lack of a difference in outcome among the treatment cohorts. We looked at administrative data for a spike in aborted treatments in mid-March 2020, and there was not any. In the survey conducted among our clients in April/May 2020, many indicated that they appreciated the option of continuing their treatment, and although considering videoconferencing second best, they showed an understanding that there was no alternative due to the lockdown (de Beurs et al., 2021a) .

In S-MHC, we limited the scope of the outcome data to the first year of treatment to homogenize treatment duration among the cohorts.

We collected data until June 2021, and treatments with a duration of more than 14 months could not be included in the videoconferencing cohort. Therefore, we decided to limit the outcome data for all cohorts to the first year of treatment.

An alternative explanation for a lack of the expected diminished treatment effect in the videoconferencing cohort might be that these patients were treated longer or more intensely. We compared the number of sessions and treatment duration among the cohorts and found that treatments of patients who transitioned from in-person to videoconferencing (Cohort 2) were longer. One might speculate that the transition to videoconferencing required an additional effort.

However, the number of sessions and treatment duration of patients treated entirely via videoconferencing was similar to treatments delivered prior to COVID. Perhaps therapists gained more experience with and grew more accustomed to videoconferencing over time. At any rate, the results showed that no longer or more intense treatment was provided in the cohort treated entirely during the COVID-19 crisis. In S-MHC, the average treatment duration was even somewhat shorter in the videoconferencing cohort, which could have resulted from more efficient contact between therapist and patient. In the survey, therapists reported that they felt more 'business-like' and mentioned that videoconferencing was more personally intense and demanding (de Beurs et al., 2021b) . Cost-effectiveness studies suggest that guided digital interventions for the treatment of depression and other disorders (Donker et al., 2015) have the potential to be a costeffective complement to treatment as usual, although more methodologically sound studies are needed (Paganini et al., 2018) . In the future, when the COVID-19 pandemic and its lockdown is further behind us, a comparison of the length of full-treatment trajectories can shed more light on the potential greater efficiency of videoconferencing psychotherapy. et al., 2015) . Furthermore, it is unlikely that the lack of a difference in outcome between the modes of treatment delivery is explained by selective non-response, as response levels for ROM were quite similar in the three cohorts within each sample. Our analyses did not reveal systematic differences between included and excluded patients in demographic of clinical characteristics. Nevertheless, potentially, treatment outcomes could be overestimated by selective inclusion of well-treatable patients at pretest or by selective attrition of treatment failures at post-test. Overestimated outcomes may obscure differences in outcome between the cohorts, which would otherwise become apparent. In particular, in S-MHC, the findings may be biased, as in S-MHC, the overall response rate was below 50%. Lowfrequency ROM is implemented in the Arkin clinics, which implies that ROM assessments were completed periodically (every 3 months); of these, we used only pretest and post-test assessments. Consequently, possible differences between cohorts in the trajectory of change were not detected. Finally, outcome was only assessed by a self-report questionnaire, the OQ-45. Although the subscale for symptomatic distress (OQ-SD) of the OQ-45 has good psychometric properties (Lambert et al., 1996) , using clients' self-reports as the only source of information may render the findings vulnerable to bias. It should be noted that self-reports do not necessarily lead to overestimated outcomes, as evidenced by Cuijpers et al. (2010) who undertook a metaanalysis to compare ratings by clinicians to self-reports by patients.

They found that self-reports render a more conservative estimate of treatment efficacy in controlled trials compared to outcome ratings of clinicians. Still, future studies might benefit from including an assessment of treatment benefit from the professional or from an independent rater.

A further limitation is that the form of digital care evaluated in the present study-videoconferencing-uses only one of the common channels for live contact between a therapist and client. In contrast, digital care may involve varying amounts of therapist contact blended with computerized tasks. Sometimes therapist contact is limited to asynchronous messages, such as email. Indeed, the present study primarily compared two modes of treatment delivery: in-person versus synchronous videoconferencing. Other forms of eHealth, such as blended eHealth, in which part of therapist involvement is replaced by interaction with the computer or asynchronous messaging, were not evaluated.

Another limitation is related to the observational design of the study. Its findings will have to be evaluated considering a major confounder: All data for treatment outcome of therapy conducted through videoconferencing were taken from time intervals within the COVID-19 crisis. The assumption that mental health patients, and the human population in general, were mentally more troubled during this time is undeniable. Indeed, Robillard et al. (2021) found that during the COVID-19 crisis depression and anxiety symptoms as well as suicidal ideation have significantly increased. Professionals were also hindered by the lockdown measures in performing therapy from home. Our survey demonstrated that many complained about lack of privacy and distraction from family members not going to work or school (de Beurs et al., 2021b) . Thus, the COVID-19

pandemic, its concurrent requirements of social distancing resulting in social isolation and COVID-19 associated fears, anxiety and worries may by itself lead to diminished outcomes of therapeutic efforts, irrespective of the delivery mode of the treatment. As the nature of this study is observational, the possible effect of the viral outbreak on psychological symptoms cannot be separated from the effect of switching to videoconferencing treatment. This is called 'history' in the listing of threats to internal validity by Campbell and Stanley (1966) : an external event occurring during the data gathering phase of a study that effects the outcome. A limitation of the present research is its quasi-experimental and uncontrolled design.

Future research should investigate the comparative efficacy of inperson and videoconferencing treatment in an RCT. Furthermore, other forms of eHealth, such as blended forms, should be evaluated in a controlled design.

The present results of this quasi-experimental study suggest that vid- 

None.

No conflicts to declare.

Data obtained for the study will be made available upon request.

All authors confirm that they have not published before and/or have not something in press around this data set. The manuscript has not been previously published and is not currently under consideration by any other journal. Additionally, all authors have approved the contents of this paper and agree to the CPP's submission policies.

Grappling with our therapeutic relationship and professional self-doubt during COVID-19: Will we use video therapy again?

Diagnostic and statistical manual of mental disorders (DSM-5 ® )

Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: A meta-analysis

Videoconferencing psychotherapy: A systematic review

Psychotherapists' acceptance of telepsychotherapy during the COVID-19 pandemic: A machine learning approach

Why coronavirus looks like a "black swan" moment for higher ed. The Chronicle

The psychological impact of quarantine and how to reduce it: Rapid review of the evidence

Experimental and quasi-experimental designs for research

Routine outcome monitoring and feedback on physical or mental health status: Evidence and theory

A perspective on client-psychologist relationships in videoconferencing psychotherapy: Literature review

Adherence in internet interventions for anxiety and depression: Systematic review

A systematic review of providers' attitudes toward telemental health via videoconferencing

How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence

Internet and mobile interventions for depression: Opportunities and challenges

Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: A meta-analysis

Comparing methods to denote treatment outcome in clinical research and benchmarking mental health care

Beeldbellen in de GGZ: de mening van cliënten

Zorgverlening in tijden van corona: de uitkomsten van een enquête over zorg-op-afstand onder medewerkers in de GGZ [Mental health care in times of corona: Experiences of professionals with eHealth

Approaches to denote treatment outcome: Clinical significance and clinical global impression compared

Routine outcome monitoring in the Netherlands: Practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice

Bias through selective inclusion and attrition: Representativeness when comparing providers performance with routine outcome monitoring data

Economic evaluations of internet interventions for mental health: A systematic review

The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance

The impact of digital technology on psychological treatments and their dissemination

Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses

The consequences of the COVID-19 pandemic on mental health and implications for clinical practice

Trust in online therapeutic relationships: The therapist's experience

Computer-aided CBT self-help for anxiety and depressive disorders: Experience of a London clinic and future directions

Survey of psychologists' telebehavioral health practices: Technology use, ethical issues, and training needs

Addressing missing data in Patient-Reported Outcome Measures (PROMS): Implications for the use of PROMS for comparing provider performance

The impact of communication technologies on life and relationship satisfaction

Experiences of psychotherapists with remote psychotherapy during the COVID-19 pandemic: Cross-sectional web-based survey study

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis

Introduction to a special issue on disclosure and concealment in psychotherapy

Comparing Skype (video calling) and in-person qualitative interview modes in a study of people with irritable bowel syndrome-An exploratory comparative analysis

The reliability and validity of the Outcome Questionnaire

Treatment of posttraumatic stress through the internet: A controlled trial

Attitudes toward e-mental health services in a community sample of adults: Online survey

Establishing and governing e-mental health care in Australia: A systematic review of challenges and a call for policy-focussed research

Multimodal e-mental health treatment for depression: A feasibility trial

Economic evaluations of internet-and mobile-based interventions for the treatment and prevention of depression: A systematic review

Demographic, organizational, and clinical practice predictors of U.S. psychologists' use of telepsychology

The COVID-19 telepsychology revolution: A national study of pandemic-based changes in US mental health care delivery

Therapeutic interventions in in-person and remote psychotherapy: Survey with psychotherapists and patients experiencing in-person and remote psychotherapy during COVID-19

Changes in provision of psychotherapy in the early weeks of the COVID-19 lockdown in Austria

Current directions in videoconferencing tele-mental health research

Emerging new psychiatric symptoms and the worsening of pre-existing mental disorders during the COVID-19 pandemic: A Canadian multisite study

Rural backwaters or front-runners? Rural telehealth in the vanguard of psychology practice

The advantages and disadvantages of online and blended therapy: Survey study amongst licensed psychotherapists in Austria

Investigating patient exclusion bias in meta-analysis

Comparing PTSD treatment retention among survivors of military sexual trauma utilizing clinical video technology and in-person approaches

A cost-effectiveness analysis to evaluate a system change in mental healthcare in the Netherlands for patients with depression or anxiety. Administration and Policy in Mental Health and

Improving implementation of eMental health for mood disorders in routine practice: Systematic review of barriers and facilitating factors

The COVID-19 pandemic: The 'black swan' for mental health care and a turning point for e-health

Telehealth transformation: COVID-19 and the rise of virtual care

The outbreak of COVID-19: An overview

Impact of COVID-19 social distancing measures on routine mental health care provision and treatment outcome for common mental disorders in the Netherlands